Improving siRNA Delivery In Vivo Through Lipid Conjugation

Osborn, Maire F., Khvorova, Anastasia·2018·Nucleic Acid Therapeutics

Cited by (138)

Items 101–138 of 138

  1. Oligonucleotide‐Linked Lipid Nanoparticles as a Versatile mRNA Nanovaccine Platform
    San Hae Im, Youseung Chung, Nevena Duskunovic, Heewon Choi, Su‐Hyung Park, Hyun Jung Chung · 2024 · Advanced Healthcare Materials
  2. Postsynthetic On-Column 2′ Functionalization of RNA by Convenient Versatile Method
    Olga A. Krasheninina, Veniamin Fishman, Alexander A. Lomzov, Alexey V. Ustinov, Alya G. Venyaminova · 2020 · International Journal of Molecular Sciences
  3. Synthesis and Exon-Skipping Properties of a 3′-Ursodeoxycholic Acid-Conjugated Oligonucleotide Targeting DMD Pre-mRNA: Pre-Synthetic versus Post-Synthetic Approach
    Elena Marchesi, Matteo Bovolenta, Lorenzo Preti, Massimo Luigi Capobianco, Kamel Mamchaoui, Monica Bertoldo, Daniela Perrone · 2021 · Molecules
  4. A programmable dual-targeting di-valent siRNA scaffold supports potent multi-gene modulation in the central nervous system
    Jillian Belgrad, Qi Tang, Samuel R. Hildebrand, Ashley Summers, Ellen Sapp, Dimas Echeverria, Daniel O’Reilly, Eric Luu, Brianna M. Bramato, Sarah E. Allen et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  5. Technology for Nucleic Acid Delivery in the Treatment of Hematological Malignancies
    Saba Abbasi Dezfouli, Hasan Uludağ, Mohammad Nasrullah, Amarnath Praphakar Rajendran, K.C.B. Remant · 2026 · Advanced Drug Delivery Reviews
  6. RNA‐Micelles as Self‐Assembling Structures for Efficient Co‐Delivery of Synergistic siRNA and Nucleoside Analogues to Treat CRC Lung Metastasis
    Kai Jin, Piotr G. Rychahou, Daniel W. Binzel, Bernard Mark Evers, Peixuan Guo · 2026 · Advanced Functional Materials
  7. Delivery Systems for Therapeutic Genome Editing: Challenges, Innovations, and Future Perspectives
    Meijia Yang, Yiqiong Song, Ziyang Wang, Ke Chao, Lifeng Li, Xu Zhang, Xiaoran Duan, Chenglong Yu, Ruyue Xue, Jie Zhao · 2026 · MedComm
  8. Multispanning membrane protein SIDT2 increases knockdown activity of gapmer antisense oligonucleotides
    Kohshi Kusumoto, Kiyomi Sasaki, Y. Uchida, Ayaka Utsumi, Tokuyuki Yoshida, Satoshi Obika, Takao Inoué, Keiichiro Okuhira · 2025 · Scientific Reports
  9. Emerging RNAi Therapies to Treat Hypertension
    Pawan Daga, Gurnoor Singh, Tushar Menon, Maryta N. Sztukowska, Dinesh Kumar Kalra · 2024 · Molecular Diagnosis & Therapy
  10. Structural Optimization of siRNA Conjugates for Albumin Binding Achieves Effective MCL1-Targeted Cancer Therapy
    Ella N. Hoogenboezem, Shrusti S. Patel, Ashley B. Cavnar, Justin Han-Je Lo, Lauren M. Babb, Nora Francini, Prarthana Patil, Juan Manuel Colazo, Danielle L. Michell, Violeta M. Sanchez et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  11. Self-delivering CRISPR RNAs for AAV Co-delivery and Genome Editing in vivo
    Han Zhang, Karen L. Kelly, Jonathan Lee, Dimas Echeverria, David Cooper, Rebecca Panwala, Zexiang Chen, Nicholas Gaston, Gregory A. Newby, Jun Xie et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  12. Lipid–drug conjugates for enhanced drug delivery and targeting
    Nayan Ranjan Ghose Bishwas, Malay K. Das · 2025 · Elsevier eBooks
  13. Cholesterol‐conjugated miR‐29b induces fetal haemoglobin expression via γ‐globin promoter demethylation in the Townes mouse model for sickle cell anaemia
    Chithra Devi Palani, Alana Smith, Xueyuan Cao, Yaqin Li, Betty S. Pace, Athena Starlard‐Davenport · 2025 · British Journal of Haematology
  14. Synthesis of Chemically Diverse siRNA‐Lipid Conjugates Enabled by Reversible Adsorption to Solid Support (RASS)
    Albert Kakkis, Linzhongyi Sun, Zhijie Xie, Maya Qaddourah, Philip E. Dawson, Brittany B. Sanchez, Brandon J. Orzolek, Florence M. Brunel, Joseph R. Stock, Robert V. Kolakowski et al. · 2025 · ChemBioChem
  15. Artificial Internalizing Receptors for Targeted Degradation of Extracellular Proteins
    Ane Bretschneider Søgaard, Rikke Fabech Hansson, Mikkel Høj Nielsen, Alexander N. Zelikin · 2025 · Advanced Science
  16. Upgrading nucleic acid and antisense therapeutics: challenges, solutions, and future directions
    Abdullah Zia, Toshifumi Yokota · 2025 · Bioanalysis
  17. Model-Assisted Process Optimization for Trivalent Ligand-siRNA Conjugation via CuAAC Click Chemistry
    Fei Pan, Shuai Yang, Rui Zhang, Jin Li, Guansai Liu, Jinsen Chen · 2025 · ACS Omega
  18. Small Interfering RNA Carriers for Oncotherapy: A Preclinical Overview
    Liliana Aranda‐Lara, Alondra Escudero-Castellanos, Maydelid Trujillo-Nolasco, Enrique Morales-Ávila, Blanca Ocampo‐García, Rigoberto Oros‐Pantoja, Virginia Sánchez Monroy, Keila Isaac‐Olivé · 2025 · Pharmaceutics
  19. Industry Practices in Oligonucleotide Tissue Biodistribution Assessment: An IQ consortium Cross-Industry Survey of Current Approaches and Emerging Trends
    Michael McCoy, Huaping Tang, Lydia Michaut, Irina Laczkovich, Girish Rajmal Chopda, L.R. Chen, Isha Taneja, C. Andrew Boswell, Guangnong Zhang · 2026 · The AAPS Journal
  20. Exploring the Potential of Receptor Silencing in the Tumor Microenvironment by RNA Interference
    KARINA MAYUMI TANI BEZERRA DE MELO, Beatriz Mendonça Alves Bandeira, Pedro Vinícius Silva Novis, Micaela Evellin dos Santos Silva, Ingrid Andrêssa de Moura, Antônio Carlos de Freitas, Anna Jéssica Duarte Silva · 2026 · Biomolecules
  21. A DNA/RNA heteroduplex oligonucleotide coupling asparagine depletion restricts FGFR2 fusion-driven intrahepatic cholangiocarcinoma
    Zhenzhen Chu, Baohuan Zhang, Xuxuan Zhou, Hui Yuan, Chongqing Gao, Lihao Liu, Yang Xiao, Jichun Zhang, Jian Hong, Junjie Liang et al. · 2023 · Molecular Therapy — Nucleic Acids
  22. Drug Delivery Systems for Muscles
    Mitsuru Naito, Mao Hori · 2024 · Springer eBooks
  23. Conjugate-mediated Delivery of RNAi-based Therapeutics: Enhancing Pharmacokinetics–Pharmacodynamics Relationships of Medicinal Oligonucleotides
    Bruno M.D.C. Godinho, Andrew H. Coles, Anastasia Khvorova · 2019 · Royal Society of Chemistry eBooks
  24. Construction path and intergenerational differences of Yan'an urban residents' red memory
    Bai Kai, Xiao-yuan KANG, Wang Bo-lin · 2021 · 自然资源学报
  25. Stratégies thérapeutiques pour l’application clinique des ARN interférents
    Elias Fattal · 2020 · Bulletin de l Académie Nationale de Médecine
  26. LncRNA LLNLR-299G3.1 promotes ESCC progression by regulating cancer related genes through RNA-chromatin interactions
    Li Tian, Yongyi Huang, Baozhen Zhang, Yi Song, Lin Yang, Qianqian Chen, Zheng Wang, Yiling Wang, Qihan He, Wenhan Yang et al. · 2022 · Research Square
  27. Systematic optimization of siRNA productive uptake into resting and activated T cells ex vivo
    A Kremer, Tatyana Ryaykenen, Réka Ágnes Haraszti · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  28. 3338 Oligonucleotide conjugates
    Andreia F. Jorge, Santiago Grijalvo, Anna Maria Aviñó, Carme Fàbrega, Ramón Eritja · 2025 · De Gruyter eBooks
  29. Transient Knockdown of RORB with Cell-Penetrating siRNA Improves Visual Function in a Proteotoxic Mouse Model of Retinitis Pigmentosa
    Chanok Son, Hyo Kyung Lee, Hyoik Jang, Chul-Woo Park, Yu-sang Lee, Daehan Lim, Dong-ki Lee, Semin Lee, Hyewon Chung · 2025 · Biomedicines
  30. Evaluating the effects of aging on distribution and gene silencing activity of lipid-siRNA conjugates delivered into cerebrospinal fluid
    Alexander P Ligocki, Alexander G. Sorets, Adam M Abdulrahman, Nora Francini, Joshua C. Park, Ju Ha Lee, William T. Ford, Sarah M. Lyons, Emma L. Fritsch, Zachary E. Lamantia et al. · 2026 · Molecular Therapy
  31. MicroRNA combinations function as synergistic network regulators of neuroblastoma differentiation
    Seth A. Lawson, Y. Zhang, Adam Kosti, Matthew J. Hart, Luiz O. F. Penalva, Alexander Pertsemlidis · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  32. Impact des immunoglobulines tronquées produites par saut d’exon dans les plasmocytes : vers des approches thérapeutiques utilisant des oligonucléotides antisens
    Jean-Marie Lambert · 2020 · theses.fr (ABES)
  33. 1′-Sugar-Tethered Cholesterol-Modified siRNAs with Variable Linker Lengths for Carrier-Free Delivery and Enhanced RNAi Efficiency
    Yurina Shimada, Ayane Tsuchida, Shin Ando, Yuri Kakisawa, Yasuko Kohda, Aya Ogata, Elsayed M. Mahmoud, Jiro Kondo, Shuichi Sakamoto, Yoshihito Ueno · 2026 · ACS Omega
  34. Lipidation of the KV1.3 blocking peptide HsTX1[R14A] alters its pharmacokinetics and biodistribution
    Lihuan Lin, Thomas R. Mitchell, Karoline Sanches, Mohammad Abdallah, Yuxiang Ren, Muhammad Asim Farooq, Hefeng Song, Jinghan Qu, Zengke Chen, William De Nardo et al. · 2026 · International Journal of Pharmaceutics
  35. siRNA–polymer conjugates for the delivery of RNAi therapeutics for the treatment of colon cancer
    Swetha Belavadi, Sampriti Paul, Sunil Kumar Kadiri, Prashant Tiwari · 2026 · Elsevier eBooks
  36. Radiolabelled Antisense miRNA Oligonucleotides for Molecular Imaging and Therapeutic Applications
    Chiara Bonanno, Giuseppe Romeo · 2026 · Pharmaceutics
  37. Synthesis and Characterization of Aminooxy Click Chemistry-Mediated Bis -Conjugates of siRNAs and Evaluation of Their RNAi Activity
    Dhrubajyoti Datta, Mark Neil Tolentino, Mimouna Madaoui, Jayanta Kundu, Kelly Wassarman, Jonathan Dudek, S. Mori, June Qin, Esther Roh, Daniel P. Donnelly et al. · 2026 · Bioconjugate Chemistry
  38. Recent Advances in Reversed‐Phase Liquid Chromatography for Therapeutic Oligonucleotide and Conjugate Characterization: From Ion‐Pairing to Green Analytical Approaches
    Quang-Dong Bui, Weronika Hewelt-Belka, Tiny Deschrijver, Martin Gilár, Sebastiaan Eeltink · 2026 · Analytical Science Advances